Labcorp Holdings Inc. (LH) vs United Therapeutics Corporation (UTHR)
A side-by-side comparison of Labcorp Holdings Inc. and United Therapeutics Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 28, 2026. Differences are shown without an overall score or investment verdict.
LH
Labcorp Holdings Inc.
$314.23HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
UTHR
United Therapeutics Corporation
$523.63HealthcareDelayed quote: Jul 28, 2026, 4:00 PM EDT
Total return — LH vs UTHR
growth of $100 · dividends reinvested · last 27yLH +5335.3%UTHR +8492.9%UTHR compounded faster
LH UTHR
LH vs UTHR: by the numbers
- •LH is the larger company ($25.77B vs $22.23B market cap).
- •UTHR trades at the lower trailing earnings multiple (19.36 vs 26.68 P/E), one valuation lens rather than an overall verdict.
- •UTHR converts more revenue to profit (40.61% vs 6.66% net margin).
- •UTHR grew revenue faster over the past five years (16.05% vs -1.58% CAGR).
- •LH pays a dividend (0.96% yield), while UTHR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | LH | UTHR |
|---|---|---|
| P/E ratio | 26.68 | 19.36 |
| Forward P/E | 16.71 | 18.79 |
| P/S ratio | 1.77 | 7.80 |
| P/B ratio | 2.86 | 4.19 |
| PEG ratio | 1.28 | 1.16 |
| EV / EBITDA | 13.89 | 15.50 |
| FCF yield | 5.54% | 4.12% |
Profitability
| Metric | LH | UTHR |
|---|---|---|
| Gross margin | 27.79% | 86.58% |
| Operating margin | 11.03% | 45.34% |
| Net margin | 6.66% | 40.61% |
| ROE | 10.79% | 21.82% |
| ROIC | 7.39% | 16.13% |
Dividends
| Metric | LH | UTHR |
|---|---|---|
| Dividend yield | 0.96% | N/A |
| Payout ratio | 27.32% | N/A |
Growth (annualized)
| Metric | LH | UTHR |
|---|---|---|
| Revenue CAGR (5Y) | -1.58% | 16.05% |
| EPS CAGR (5Y) | -8.00% | 20.93% |
| FCF CAGR (5Y) | -12.63% | 12.12% |
| Total return CAGR (5Y) | 5.72% | 23.07% |
Frequently asked
- Which has the lower trailing P/E, LH or UTHR?
- UTHR has the lower trailing P/E: LH trades at 26.68 and UTHR at 19.36. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, LH or UTHR?
- Over the past five years, UTHR grew revenue faster — LH at a -1.58% CAGR versus UTHR at 16.05%.
- Does LH or UTHR pay a bigger dividend?
- LH pays a dividend (0.96% yield), while UTHR has no payments in the available dividend history.
- Is LH or UTHR more profitable?
- UTHR runs the higher net margin — LH at 6.66% versus UTHR at 40.61%.
- How have LH and UTHR total returns compared?
- Over the past 10 years, LH delivered 10.44% and UTHR delivered 15.97% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Labcorp P/E ratioUnited Therapeutics P/E ratioLabcorp dividend yieldUnited Therapeutics dividend yieldLabcorp ROEUnited Therapeutics ROELabcorp operating marginUnited Therapeutics operating marginLabcorp revenue growthUnited Therapeutics revenue growthLabcorp free cash flowUnited Therapeutics free cash flow
Labcorp & United Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 28, 2026.